Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion type Assertion NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_head.
- NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion wasGeneratedBy ECO_0000203 NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_provenance.
- NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion wasDerivedFrom befree-20140225 NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_provenance.
- NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion SIO_000772 14976243 NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_provenance.
- NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion evidence source_evidence_literature NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_provenance.
- NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_assertion description "[Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558580.RA4n4zoQy2-AkL2dp5KaoOQRh44T74XkH1-GR_2cYlTSE130_provenance.